
Nov 4, 2026
Ensysce Biosciences Announces Leadership Changes Including CEO to COO Transition Post-2026 Annual Meeting
Ensysce Biosciences (NASDAQ: ENSC) has announced significant leadership changes, effective after its December 14, 2026 annual stockholder meeting. Dr. Lynn Kirkpatrick will transition from CEO to COO, while James Morrisson will assume the CEO role. Board member Will Chang is also set to resign.
Company relevance
100.00%
Company sentiment
Neutral
Overall sentiment
Neutral